Nocturnal Plasma Melatonin and Alpha-Melanocyte Stimulating Hormone Levels During Exacerbation of Multiple Sclerosis

References

• Adachi M., Volk B. W., Schneck L., Relkin R. Ultrastructural alterations of endocrine glands in Tay-Sachs' disease. American Journal of Clinical Pathology 1972; 57: 557–561
   PubMed Web of Science ®Google Scholar
• Adeloye A., Felson B. Incidence of normal pineal gland calcification in skull roengenograms of black and white Americans. American Journal of Radiology 1974; 122: 503–507
   Google Scholar
• Arendt J., Panier L., Sizonenko P. C. Melatonin radioimmunoassay. Journal of Clinical Endocrinology and Metabolism 1975; 40: 347–350
   PubMed Web of Science ®Google Scholar
• Arendt J., Wirz-Justice A., Bradtke J., Kornemark M. Long-term studies on immuno-reactive human melatonin. Annals of Clinical Biochemistry 1979; 16: 307–312
   PubMed Web of Science ®Google Scholar
• Bal A., Vazquez-Barquero J. L., Pena C., Miro J., Berciano J. A. Psychiatric aspects of multiple sclerosis. Acta Psychiatrica Scandinavica 1990; 83: 292–296
   Web of Science ®Google Scholar
• Bamford C. R., Sibley W. A., Thies C. Seasonal variation of MS exacerbations in Arizona. Neurology 1983; 33: 1537–1544
   PubMed Web of Science ®Google Scholar
• Baretz R. M., Stephenson G. R. Emotional responses to multiple sclerosis. Psychosomatics 1981; 22: 117–127
   PubMed Web of Science ®Google Scholar
• Bertolini A., Gessa G. L. Behavioral effects of ACTH and MSH peptides. Journal of Endocrine Investigations 1981; 4: 241–251
   PubMed Web of Science ®Google Scholar
• Bertolini A., Vergoni W., Gessa G. L. Induction of sexual excitement by the action of adrenocorticotrophic hormone in brain. Nature 1969; 221: 667–669
   PubMedGoogle Scholar
• Birau N., Pavel S., Meyer C. Melatonin serum concentration in the waking state of narcoleptics. IP.CS Medical Science 1982; 10: 199
   Google Scholar
• Birau N., Alexander D., Berhthold S., Meyer C. Low nocturnal serum concentration in anorexia nervosa-further evidence for body weight influence. 1RCS Medical Science 1984; 12: 477–479
   Google Scholar
• Borg S., Mossberg D., Wetterberg L. Low urinary melatonin concentration in alcoholics–a possible marker of a low central noradrenaline metabolism. Neuroendocrinology letters 1983; 5: 411
   Google Scholar
• Brain W. R. Multiple sclerosis. Brain's diseases of the nervous system, J. N. Walton. Oxford University Press, Oxford 1977; 544–546
   Google Scholar
• Brambilla F., Cazzullo C. L., Smeraldi E., Zibetti A. Endocrine function in multiple sclerosis: possible correlation with immunitary phenomena. Acta Neurologica (Napoli) 1974; 29: 618–625
   PubMedGoogle Scholar
• Brown R., Kocsis J. H., Caroff S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. American Journal of Psychiatry 1985; 142: 811–816
   PubMed Web of Science ®Google Scholar
• Claustrat B., Brun J., Mallo C., Faure A., Zaidan R., Touitou Y., Chazot G. Melatonin in humans: methodological and ethical problems in clinical studies. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; 321–328
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Daramola G. F., Olowu A. O. Physiological and radiological implications of a low incidence of pineal calcification in nigeria. Neuroendocrinology 1972; 9: 41–57
   PubMed Web of Science ®Google Scholar
• Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience & Bio-behavioral Reviews 1980; 4: 451–458
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Dean G. Annual incidence, prevalence and mortality of multiple sclerosis in white South African-bom and in white immigrants to South Africa. British Medical Journal 1967; 2: 724–730
   PubMed Web of Science ®Google Scholar
• De Wied D. Influence of anterior pituitary on avoidance learning and escape behavior. American Journal of Physiology 1964; 207: 255–259
   PubMed Web of Science ®Google Scholar
• Dunn A. J., Green E. J., Issacson R. L. Intracerebral adrenocorticotropic hormone mediates novelty-induced grooming in the rat. Science 1974; 203: 281–283
   Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Eskay R. L., Giraud P., Oliver C., Brownstein M. J. Distribution of alpha-melanocyte-stimulating hormone in the rat brain: evidence that alpha-MSH-containing cells in the arcuate region send projections to extrahypothalamic areas. Brain Research 1979; 178: 55–67
   PubMedGoogle Scholar
• Fanget F., Claustrat B., Dalery J., Brub J., Terra J. L., Marie-Cardine M., Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry 1989; 25: 499–501
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C., Crow T. J. Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clinical Endocrinology 1982; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Freeman W. Treatment with special reference to fever therapy prolonged rest and diamatotherapy. Medical Annals of the District of Columbia 1944; 13: 58–67
   Google Scholar
• Frick E., Scheid-Seydel L. Untersuchungen mil markirtem globulin zur frage der abstam-mung der liquoreiweisskorper. Klinische Wochenschrift 1958; 36: 857–863
   PubMedGoogle Scholar
• Garfield D. A. S. Multiple sclerosis and affective disorder. 2 case reports of mania with psychosis. Psychotherapy & Psychosomatics 1985; 44: 25–33
   PubMed Web of Science ®Google Scholar
• Garrick N. A., Tamarkin L., Taylor P. L., Markey S. P., Murphy D. L. Light and propranolol suppress the nocturnal elevation of serotonin in the cerebrospinal fluid of rhesus monkeys. Science 1983; 221: 474–476
   PubMedGoogle Scholar
• Glun J. R., Lipton J. M. Hypothermic and antipyretic effects of centrally administered ACTH (1–24) and alpha-melanotropin. Peptides 1981; 2: 177–188
   PubMedGoogle Scholar
• Goodstein R. K., Ferrell R. B. Multiple sclerosis presenting as depressive illness. Diseases of the Nervous System 1977; 38: 127–131
   PubMedGoogle Scholar
• Gupta D., Riedel L., Frick H. J. Circulating melatonin in children in relation to puberty. endocrine disorders, functional tests and racial origin. Neuroendocrinology Letters 1983; 5: 63–78
   Web of Science ®Google Scholar
• Hassan M. M., Bottoms S. F., Evans M. I., Dombrowski M. P., Mariona F. G., Mukherjee A. B. Fetal alpha-melanocyte-stimulating hormone levels: No correlation with late fetal growth but increased with diabetes mellitus. American Journal of Obstetrics and Gynecology 1986; 154: 428–430
   PubMed Web of Science ®Google Scholar
• Hogben L. T., Winton F. R. Studies on the pituitary melanophore stimulant in posterior lobe extracts. Biochemistry Journal 1992; 16: 619–630
   Google Scholar
• Honnebier W. J., Swaab D. F. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. Journal of Obstetrics and Gynecology 1973; 80: 577–581
   Google Scholar
• Humbert W., Pevet P. Calcium content and concretions of pineal glands of young and old rats. A scanning and x-ray microanalytical study. Cell and Tissue Research 1991; 263: 593–596
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Falck S. C. L-tryptophan and neuroendocrine regulation in neurologic patients: gonadotropir secretion, sexual motivation and responsiveness during L-tryptophan treatment in patients with multiple sclerosis (MS). Psychoneuroendocrinology 1977; 2: 359–363
   PubMed Web of Science ®Google Scholar
• Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after ur ilateral microinjection of adrenocorticotropin (1–24) in rat brainstem. Science 1983; 218: 175–177
   Web of Science ®Google Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune react ons in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Jegou S., Delbende C., Tranchand-Bunel D., Leroux P., Vaudry H. Alpha-melanocyte-stimulating hormone (alpha-MSH) release from perifused rat hypothalamic slices. Brain Research 1987; 413: 259–266
   PubMed Web of Science ®Google Scholar
• Joffe R. T., Lippert G. P., Gray T. A. Mood disorder and multiple sclerosis. Archives of Neurology 1987; 44: 376–378
   PubMed Web of Science ®Google Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–45
   PubMed Web of Science ®Google Scholar
• Kamalian N., Keesey R. E., ZuRhein G. M. Lateral hypothalamic demyelination and cachexia in a case of “maligant” multiple sclerosis. Neurology 1975; 25: 25–30
   PubMed Web of Science ®Google Scholar
• Kamback D. O., Rich R. A., Relkin R. Effect of pinealectomy on fatty acid composition of rat brain myelin. Endocrinology 1982; 110: 907–909
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Schally A. V. Autoregulation of release of melnocyte stimulating hormone from rat pituitary. Nature 1967; 213: 1238–1240
   Google Scholar
• Kastin A. J., Redding T. W., Schally A. V. MSH activity in rat pituitaries after pine-alectomy. Proceedings of the Society of Experimental Biology and Medicine 1967a; 124: 1275–1277
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Schally A. V., Viosca S., Barrett L., Redding T. W. MSH activity in the pituitaries of rats exposed to constant illumination. Neuroendocrinology 1967b; 2: 257–261
   Google Scholar
• Kastin A. J., Arimura A., Viosca S., Barrett L., Schally A. V. MSH activity in pituitaries of rats exposed to stress. Neuroendocrinology 1967c; 2: 200–208
   Google Scholar
• Kastin A. J., Viosca S., Nair R. M. G., Schally A. V., Miller M. C. Interactions between pineal, hypothalamus and pituitary involving melatonin, MSH release-inhibiting factor and MSH. Endocrinology 1972; 91: 1323–1328
   PubMed Web of Science ®Google Scholar
• Kellner C. H., Davenport Y., Post R. M., Ross R. J. Rapidly cycling bipolar disorder and multiple sclerosis. American Journal of Psychiatry 1984; 141: 112–113
   PubMed Web of Science ®Google Scholar
• Khachaturian H., Lewis M. E., Tsou K. Beta-endorphin, alpha-MSH, ACTH and related peptides. Handbook of chemical neuroanatomy, A. Bjorklund, T. Hokfelt. Elsevier Science Publishing, New York 1985; 216–272
   Google Scholar
• Kira J. I., Harada M., Yamaguchi Y., Shida N., Goto I. Hyperprolactinemia in multiple sclerosis. Journal of the Neurological Sciences 1991; 102: 61–66
   PubMed Web of Science ®Google Scholar
• Klapps P., Seyfert S., Fischer T., Scherbaum W. A. Endocrine function in multiple sclerosis. Acta Neurologica Scandinavica 1992; 85: 353–357
   PubMedGoogle Scholar
• Kleber G., Gramsch C., Hollt V., Mehraein P., Pasi A., Herz A. Extrahypothalamic corticotropin and alpha-melanotropin in human brain. Neuroendocrinology 1980; 31: 39–45
   PubMedGoogle Scholar
• Klein D. C. The pineal gland: a model of neuroendocrine regulation. The hypothalamus, S. Reichlin, R. J. Baldessarini, J. B. Martin. Raven Press, New York 1978; 303–327
   Google Scholar
• Kordon C., Enjalbert A., Hery M., Joseph-Bravo P. I., Rotsztejn W., Ruberg M. Role of neurotransmitters in the control adenohypophyseal secretion. Handbook of the hypothalamus, P. J. Morgane, J. Panksepp. Marcel Dekker, New York 1980; vol. 2: 253–306
   Google Scholar
• Krause D. N., Dubocovich M. L. Regulatory sites in the melatonin system of mammals. Trends in Neurosciences 1990; 13: 464–470
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F., Beebe G. W., Norman J. E. Epidemiology of multiple sclerosis in US veterans I. Race, sex, and geographic distribution. Neurology 1979; 29: 1228–1235
   PubMed Web of Science ®Google Scholar
• Levine N., Sheftel S. N., Eytan T., Dorr R. T., Hadley M. E., Weinrach J. C., Ertl G. A., Toth K., McGee D. L., Hruby V. J. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. Journal of the American Medical Association 1991; 266: 2730–2736
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Wehr T. A., Gold P. W., Goodwin F. K. Plasma melatonin in manic-depressive illness. Catecholamines: basic and clinical frontiers, E. Usdin, I. J. Kopin, J. Barchas. Pergamon Press, Elmsford, NY 1979; 1173–1175
   Google Scholar
• Lewy A. J., Wehr T. A., Goodwin F. K., Newsome D. A. Light suppresses melatonin secretion in humans. Science 1980; 210: 1267–1270
   PubMed Web of Science ®Google Scholar
• Lukaszyk A., Reiter R. J. Histophysiological evidence for the secretion of polypeptides by the pineal gland. American Journal of Anatomy 1975; 143: 451–464
   PubMedGoogle Scholar
• Lumsden C. E. The neuropathology of multiple sclerosis and other demyelinating diseases. Handbook of clinical neurology, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1968; vol. 9: 217–309
   Google Scholar
• Macpherson P., Matheson M. S. Comparison of calcification of pineal, habenular commissure and choroid plexus in plain films and computed tomography. Neuroradiology 1979; 18: 67–72
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987a; vol. 44: 277–279
   Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science 1987b; 496: 67–77
   PubMed Web of Science ®Google Scholar
• Martin P. R., Higa S., Burns S., Tamarkin L., Ebert M. H., Markey S. P. Decreased 6-hydroxymelatonin excretion in Korsakoff s psychosis. Neurology 1984; 34: 966–968
   PubMedGoogle Scholar
• Matthews W. B., Acheson E. D., Batchelor J. R., Weller R. O. McAlpines multiple sclerosis. Churchill Livingstone, Edinburgh 1985
   Google Scholar
• McLntyre I. M., Judd F. K., Burrows G. D., Armstrong S. M., Norman T. R. Plasma concentrations of melatonin in panic disorder. American Journal of Psychiatry 1990; 147: 462–464
   PubMedGoogle Scholar
• Miles A., Philbrick D. R. S. Melatonin and psychiatry. Biological Psychiatry 1988; 23: 405–425
   PubMed Web of Science ®Google Scholar
• Miller L. H., Kastin A. J., Sandman C. A., Fink M., Van Veen W. J. Polypeptide influence on attention, memory and anxiety in man. Pharmacology Biochemistry and Behavior 1974; 2: 663–668
   PubMed Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psvchia-try 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Moore R. Y. Central neural control of circadian rhythms. Frontiers in neuroendocrinology 1, W. F. Ganong, L. Martin. Raven Press, New York 1978; 185
   Google Scholar
• Namboodiri M. A. A., Sugden D., Klein D. C., Mefford I. N. 5-hydroxytryptophan elevates serum melatonin. Science 1983; 221: 659–661
   PubMed Web of Science ®Google Scholar
• Nordlund J. J. Alpha-melanocyte-stimulating hormone. A ubiquitous cytokine with pigmenting effects. Journal of the American Medical Association 1991; 266: 2753–2754
   PubMed Web of Science ®Google Scholar
• Norman J. E., Kurtzke J. F., Beebe G. W. Epidemiology of multiple sclerosis in US veterans 2. Latitude, climate and the risk of multiple sclerosis. Journal of Chronic Disease 1983; 36: 551–560
   PubMedGoogle Scholar
• O'Donohue T. L., Jakobowitz D. M. Studies on alpha-melanotropin in the central nervous system. Polypeptide hormones, R. F. Beers, E. G. Bassett. Raven Press, New York 1980; 203–222
   Google Scholar
• O'Donohue T. L., Dorsa D. M. The opiomelanotrophinergic neuronal and endocrine systems. Peptides 1982; 3: 353–395
   PubMed Web of Science ®Google Scholar
• O'Donohue T. L., Miler R. L., Jacobowitz D. M. Identification, characterization and stereotaxic mapping of intraneuronal alpha-melanoxyte-stimulating hormone-like immunoreactive peptides in discrete regions of the rat brain. Brain Research 1979; 176: 101–123
   PubMed Web of Science ®Google Scholar
• O'Donohue T. L., Handelmann G. E., Chaconas T., Miller R. L., Jacobowitz D. M. Evidence that N-acetylation regulates behavioral activity of alpha-MSH in the rat and human central nervous system. Peptides 1981; 2: 333–344
   PubMedGoogle Scholar
• Olcese J., Reuss S., Stehle S., Steinlechner S., Vollrath L. The mammalian pineal and retinae as geomagnetic field detectors. Fundamentals and clinics in pineal research, G. P. Trentini, C. DeGaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 79–82
   Google Scholar
• O'Reilly M. A. R., O'Reilly P. M. R. Temporal influences on relapses of multiple sclerosis. European Neurology 1991; 31: 391–395
   PubMed Web of Science ®Google Scholar
• Oxenkrug G., McLntyre I. Stress-induced synthesis of melatonin: possible involvement of the endogenous inhibitor (tribulin). Life Sciences 1985; 37: 1743–1746
   PubMedGoogle Scholar
• Pelham R. W., Vaughan G. M., Sandock K. L., Vaughan M. K. Twenty-four-hour cycle of a melatonin-like substance in the plasma of human males. Clinical Endocrinology 1973; 37: 341–344
   Web of Science ®Google Scholar
• Peters G. Multiple Sklerose. Handbuch der speziellen pathologischen anatomie und histologic, W. Scholz. Springer Verlag, Berlin 1958; 525
   Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience 1988; 39: 165–175
   PubMed Web of Science ®Google Scholar
• Pique L., Jegou S., Bertagna X., Javoy-Agid F., Seurin D., Proeschel M. F., Girard F., Agid Y., Vaudry H., Luton J. P. Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients. Neuroscience Letters 1985; 54: 141–146
   PubMed Web of Science ®Google Scholar
• Poser C. M., Paty D. W., Scheinberg L. New diagnostic criteria for multiple sclerosis; guidelines for research protocols. Annals of Neurology 1983; 13: 227–231
   PubMed Web of Science ®Google Scholar
• Poser S., Kreikenbaum K., Konig A., Poser W., Evers P., Wikstrom J. Endokrinolo-gische Befunde bei Patientinen mit Multiple Sklerose. Gehurtshilfe und Frauenheilkunde 1981; 41: 353–358
   PubMedGoogle Scholar
• Prineas J. W. The etiology and pathogenesis of multiple sclerosis. Multiple sclerosis and other demyelinating diseases, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1970; 107–160
   Google Scholar
• Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Laboratory Investigations 1978; 38: 409–421
   PubMed Web of Science ®Google Scholar
• Quay W. B. Pineal chemistry. Thomas, Springfield 1974; 54–58
   Google Scholar
• Quercy P., de Lachaud R., Durand R. Sur ľepiphyse et des formations paraepiphysaires chez homme adulte. Reveu Neuroogique 1938; 69: 483–490
   Google Scholar
• Rainero I., Kaye J. A., May C., Durso R., Katz D. I., Albert M. L., Wolfe N., Pinessi L., Friedland R. P., Rapoport S. I. Alpha-Melanocyte-stimulating hormonelike immu-noreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease. Archives of Neurology 1988; 45: 1224–1227
   PubMedGoogle Scholar
• Rainero I., May C., Kaye J. A., Friedland R. P., Rapoport S. I. CSF alpha-MSH in dementia of the Alzheimer's type. Neurology 1988b; 38: 1281–1284
   PubMed Web of Science ®Google Scholar
• Regelson W., Pierpaoli W. Melatonin: a rediscovered antitumor hormone. Its relation to surface receptor sex steroid metabolism. Immunologic response and chronobiologic factors in tumor growth and therapy. Cancer Investigation 1987; 5: 379–385
   PubMed Web of Science ®Google Scholar
• Reiter R. J., Troiani M. E. Pineal responses to stress are different during the day and at night. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1978; vol. 44: 281–284
   Google Scholar
• Renfrew J. W., May C., Tamarkin L. Orcadian rhythms in Alzheimer's disease. Neuro-science Abstracts 1987; 1: 322
   Google Scholar
• Reppert S. M., Klein D. C. Mammalian pineal gland: basic and clinical aspects. The endocrine functions of the brain, M. Motta. Raven Press, New York 1980; 327–371
   Google Scholar
• Reuss S., Olcese J., Vollrath L. Electrical stimulation of the hypothalamic paraventricular nuclei inhibits pineal melatonin synthesis in male rats. Neuroendocrinology 1985; 41: 192–196
   PubMed Web of Science ®Google Scholar
• Ronnekleiv O. K., Kelly M. J., Wuttke W. Single unit recordings in the rat pineal gland: evidence for habenulo-pineal neural connections. Experimental Brain Research 1980; 39: 187–192
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin production decreases with age. Journal of Pineal Research 1986; 3: 379–388
   PubMed Web of Science ®Google Scholar
• Sandyk R. Alpha melanocyte stimulating hormone in Tourette's syndrome. International Journal of Neuroscience 1989; 44: 161–164
   PubMed Web of Science ®Google Scholar
• Sandyk R. Coexisting bipolar affective disorder and multiple sclerosis: The role of the pineal gland. International Journal of Neuroscience 1991; 59: 267–270
   PubMed Web of Science ®Google Scholar
• Sandyk R. The pineal gland and multiple sclerosis., (Editorial). International Journal of Neuroscience 1992; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. Treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience
   Web of Science ®Google Scholar
• Sandyk R., Kay S. R. Pineal melatonin in schizophrenia: a review and hypothesis. Schizophrenia Bulletin 1990; 16: 653–662
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The pineal gland in multiple sclerosis. International Journal of Neuroscience 1991; 61: 61–67
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I., Kay S. R. Pineal gland calcification and tardive dyskinesia. Lancet 1990; 335: 1528
   PubMed Web of Science ®Google Scholar
• Schiffer R. B. The spectrum of depression in multiple sclerosis. An approach for clinical management. Archives of Neurology 1987; 44: 596–599
   PubMedGoogle Scholar
• Schiffer R. B., Caine E. D., Bamford K. A. Depressive episodes in patients with multiple sclerosis. American Journal of Psychiatry 1983; 140: 1498–1500
   PubMed Web of Science ®Google Scholar
• Schiffer R. B., Wineman N. M., Weitkamp L. R. Association between bipolart affective disorder and multiple sclerosis. American Journal of Psychiatry 1986; 143: 94–95
   PubMed Web of Science ®Google Scholar
• Shibasaki H. Clinical and epidemiological aspects of multiple sclerosis in Asia. Progress in Clinical Neurosciences 1985; 2: 56–64
   Google Scholar
• Sibley W. A., Foley J. M. Seasonal variation in multiple sclerosis and retrobulbar neuritis in northeastern ohio. Transmission of the American Neurological Association 1965; 90: 295–297
   Google Scholar
• Sibley W. A., Paty D. W. A comparison of multiple sclerosis in Arizona (USA) and Ontario (Canada)-preliminary report. Acta Neurologica Scandinavica 1981; 64((suppl 87))60–65
   Google Scholar
• Silman R. E., Leone R. M., Hooper R. J. L., Pearce M. A. Melatonin, the pineal gland and human puberty. Nature 1979; 282: 301–303
   PubMed Web of Science ®Google Scholar
• Skene D. J., Vivien-Roels B., Sparks D. L., Hunsaker J. C., Pevet P., Ravid D., Swaab D. F. Daily variation in the concentration of melatonin and 5-methoxytryptophan in the human pineal gland: effect of age and Alzheimer's disease. Brain Research 1992; 528: 170–174
   Google Scholar
• Smith J. A., Padwick D., Mee T. J. X., Minneman K. P., Bird E. D. Synchronous nyctohemeral rhythms in human blood melatonin and in human post-mortem pineal enzyme. Clinical Endocrinology 1977; 6: 219–225
   PubMedGoogle Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stanley M., Brown G. M. Melatonin levels are reduced in the pineal glands of suicide victims. Psychopharmacology Bulletin 1989; 24: 484–488
   Google Scholar
• Strand F. L., Cayer A. A modulatory effect of pituitary polypeptides on peripheral nerve and muscle. Progress in Brain Research 1975; 42: 187–194
   PubMedGoogle Scholar
• Strand F. L., Stoboy H., Cayer A. A possible direct action of ACTH on nerve and muscle. Neuroendocrinology 1974; 13: 1–20
   Google Scholar
• Strand F. L., Cayer A., Gonzalez E., Stoboy H. Peptide enhancement of neuromuscular function: animal and clinical studies. Pharmacology, Biochemistry and Behavior 1976; 5((suppl 1))179–187
   PubMedGoogle Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Taub R. G., Rucker C. W. The relationship of retrobulbar neuritis to multiple sclerosis. American Journal of Opthalmology 1954; 37: 494–497
   PubMed Web of Science ®Google Scholar
• Tetsuo M., Markey S. P., Kopin I. J. Measurement of 6-hydroxymelatonin in human urine and its clinical variations. Life Sciences 1980; 27: 105–109
   PubMed Web of Science ®Google Scholar
• Torre E., Celis M. E., Chiocchio S. R. Alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): Influence of dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP). Peptides 1984; 5: 669–674
   PubMed Web of Science ®Google Scholar
• Touitou Y., Bogdan A., Claustrat B., Touitou C. Drugs affecting melatonin secretion in man. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 349–356
   Google Scholar
• Trentini G. P., De Gaetani S. F., Criscuolo M., Migaldi M., Ferrari G. Pineal calcification in different physiopathological conditions in humans. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; 291–304
   Google Scholar
• Vollrath L. Functional anatomy of the human pineal gland. The pineal gland, R. J. Reiter. Raven Press, New York 1984; 285–322
   Google Scholar
• Waldenlind E., Ekbom K., Friberg F. Decreased nocturnal serum melatonin levels during active cluster headache periods. Opuscula Medicine 1984; 29: 109–112
   Google Scholar
• Waldhauser F., Weiszenbacher G., Zeitlhuber U., Waldhauser M., Frisch H., Wurtman R. J. Fall in nocturnal serum melatonin during prepuberty and pubescence. iMncet 1986; 1: 362–365
   Google Scholar
• Watson S. J., Akil H. Alpha-MSH in rat brain: occurrence within and outside brain beta-endorphin neurons. Brain Research 1980; 182: 217–223
   PubMed Web of Science ®Google Scholar
• Welsh M. G. Pineal calcification: structural and functional aspects. Pineal Research Reviews 1985; 3: 41–68
   Google Scholar
• Wetterberg L. Melatonin in humans physiological and clinical studies. Journal of Neural Transmission 1978; 13: 289–310, (suppl)
   Google Scholar
• Winkler P., Helmke K. Age-related incidence of pineal gland calcification in children. Journal of Neural Transmission 1986; 21: 480–481, (suppl)
   Google Scholar
• Wuetrich R., Rieder H. P. The seasonal incidence of multiple sclerosis in Switzerland. European Neurology 1970; 3: 257–264
   PubMed Web of Science ®Google Scholar
• Zeigler L. H. Multiple sclerosis: a clinical review and follow-up study. Minnesota Medicine 1929; 12: 778–783
   Google Scholar
• Zimmerman H. M., Netzky M. G. The pathology of multiple sclerosis. Research Publications of the Association for Research in Nervous and Mental Disease 1950; 28: 271–279
   PubMedGoogle Scholar
• Zimmerman R. A., Bilaniuk L. T. Age-related incidence of pineal calcification detected by computed tomography. Radiology 1982; 142: 659–662
   PubMed Web of Science ®Google Scholar